Welcome: Guest | Site Use Options | Register | Login |

Galileo Pharmaceuticals Inc

Galileo Pharmaceuticals Inc

Profile last edited on: 7/27/2018
5301 Patrick Henry Drive
Santa Clara, CA 95054
  (408) 654-5830
Business Identifier: Small molecule therapeutics to treat metabolic diseases
Public Profile:
Initially doing business a Galileo Laboratories and organized around evidence-based nutraceuticals and pharmaceuticals, the firm was renamed Galileo Pharmaceuticals, Inc., with a flcous shifted to the discovery and development of therapeutics targeting redox signaling metabolic pathways. The company is developing a pipeline of treatments for diabetes and arthritis. Principals of Galileo are relocated to other concerns but with no clear indication of what happened to the firm itself

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Metabolic Engineering for Performance Enhancement

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920